Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox Block of the Otic Ganglion in Chronic Cluster Headache
NCT03066635Phase 2Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Apr 2017
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in Cluster Headache (CH), sponsored by Norwegian University of Science and Technology. Started Apr 2017; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NCT03066635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03066635.